{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T14:26:59Z","timestamp":1762957619810,"version":"3.40.5"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T00:00:00Z","timestamp":1747440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T00:00:00Z","timestamp":1747440000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11093-0","type":"journal-article","created":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T16:25:00Z","timestamp":1747499100000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Tuberculosis mortality and drug resistance among patients under TB treatment before and during COVID-19 in Burundi: a case\u2013control study"],"prefix":"10.1186","volume":"25","author":[{"given":"Arnaud","family":"Iradukunda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fentabil","family":"Getnet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel Nene","family":"Odjidja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,17]]},"reference":[{"key":"11093_CR1","unstructured":"World Health Organization. Global tuberculosis report 2024. Geneva: WHO; 2024. Available from: https:\/\/www.who.int\/teams\/global-programme-on-tuberculosis-and-lung-health\/tb-reports\/global-tuberculosis-report-2024."},{"key":"11093_CR2","unstructured":"World Health Organization. WHO global lists of high burden countries for tuberculosis (TB), TB\/HIV and multidrug\/ rifampicin-resistant TB (MDR\/RR-TB), 2021\u20132025: background document. Geneva. World Health Organization (https:\/\/apps.who.int\/iris\/handle\/10665\/341980)."},{"key":"11093_CR3","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1192","volume-title":"Don\u2019t forget chronic lung and immune conditions during covid-19, says WHO","author":"J Thornton","year":"2020","unstructured":"Thornton J. Don\u2019t forget chronic lung and immune conditions during covid-19, says WHO. In.: British Medical Journal Publishing Group; 2020."},{"key":"11093_CR4","doi-asserted-by":"crossref","unstructured":"Chakaya J, Khan M, Ntoumi F, Aklillu E, Fatima R, Mwaba P, Kapata N, Mfinanga S, Hasnain SE, Katoto PD: Global Tuberculosis Report 2020\u2013Reflections on the Global TB burden, treatment and prevention efforts. Int J Infect Dis. 2021.","DOI":"10.1016\/j.ijid.2021.02.107"},{"issue":"1","key":"11093_CR5","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1016\/S2666-5247(22)00359-7","volume":"4","author":"S Bagcchi","year":"2023","unstructured":"Bagcchi S. WHO\u2019s global tuberculosis report 2022. Lancet Microbe. 2023;4(1):e20.","journal-title":"Lancet Microbe"},{"key":"11093_CR6","doi-asserted-by":"publisher","unstructured":"Faisal S. Global Tuberculosis Epidemiology. In: Cardona P-J, Gagneux S, \u00e9diteurs. Tuberculosis: Integrated Studies for a Complex Disease. Cham: Springer; 2023. p. 17\u201331. https:\/\/doi.org\/10.1007\/978-3-031-15955-8_2.","DOI":"10.1007\/978-3-031-15955-8_2"},{"issue":"6","key":"11093_CR7","doi-asserted-by":"publisher","first-page":"436","DOI":"10.5588\/ijtld.21.0148","volume":"25","author":"CF McQuaid","year":"2021","unstructured":"McQuaid CF, Vassall A, Cohen T, Fiekert K, White RG. The impact of COVID-19 on TB: a review of the data. Int J Tuberc Lung Dis. 2021;25(6):436\u201346.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"2","key":"11093_CR8","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.pulmoe.2020.12.012","volume":"27","author":"D Visca","year":"2021","unstructured":"Visca D, Ong C, Tiberi S, Centis R, D\u2019ambrosio L, Chen B, Mueller J, Mueller P, Duarte R, Dalcolmo M. Tuberculosis and COVID-19 interaction: a review of biological, clinical and public health effects. Pulmonology. 2021;27(2):151\u201365.","journal-title":"Pulmonology"},{"key":"11093_CR9","doi-asserted-by":"publisher","first-page":"102020","DOI":"10.1016\/j.tube.2020.102020","volume":"126","author":"GT Mousquer","year":"2021","unstructured":"Mousquer GT, Peres A, Fiegenbaum M. Pathology of TB\/COVID-19 co-infection: the phantom menace. Tuberculosis. 2021;126:102020.","journal-title":"Tuberculosis"},{"key":"11093_CR10","doi-asserted-by":"publisher","unstructured":"Migliori GB, Nardell E, Yedilbayev A, D'Ambrosio L, Centis R, Tadolini M, Van Den Boom M, Ehsani S, Sotgiu G, Dara M. Reducing tuberculosis transmission: A consensus document from the World Health Organization Regional Office for Europe. Eur Respir J. 2019;53(6):1900391. https:\/\/doi.org\/10.1183\/13993003.00391-2019.","DOI":"10.1183\/13993003.00391-2019"},{"key":"11093_CR11","doi-asserted-by":"publisher","unstructured":"Shariq M, Sheikh JA, Quadir N, Sharma N, Hasnain SE, Ehtesham NZ. COVID-19 andtuberculosis: The double whammy of respiratory pathogens. Eur Respir Rev. 2022;31(164):210264. https:\/\/doi.org\/10.1183\/16000617.0264-2021.","DOI":"10.1183\/16000617.0264-2021"},{"issue":"8","key":"11093_CR12","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1093\/heapol\/czad046","volume":"38","author":"M Haacker","year":"2023","unstructured":"Haacker M. Contributions of declining mortality, overall and from HIV, TB and malaria, to reduced health inequality and inequity across countries. Health Policy Plan. 2023;38(8):939\u201348.","journal-title":"Health Policy Plan"},{"issue":"10273","key":"11093_CR13","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/S0140-6736(21)00309-3","volume":"397","author":"R Horton","year":"2021","unstructured":"Horton R. Offline: COVID-19 and the convergence of nations. The Lancet. 2021;397(10273):458.","journal-title":"The Lancet"},{"issue":"5","key":"11093_CR14","doi-asserted-by":"publisher","first-page":"544","DOI":"10.5588\/ijtld.20.0151","volume":"24","author":"M Dara","year":"2020","unstructured":"Dara M, Sotgiu G, Reichler M, Chiang C, Chee C, Migliori G. New diseases and old threats: lessons from tuberculosis for the COVID-19 response. Int J Tuberc Lung Dis. 2020;24(5):544\u20135.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"3","key":"11093_CR15","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3390\/tropicalmed8030165","volume":"8","author":"AT Andom","year":"2023","unstructured":"Andom AT, Fejfar D, Yuen CM, Ndayizigiye M, Mugunga JC, Mukherjee JS. The Impact of COVID-19 on Tuberculosis Program Performance in the Kingdom of Lesotho. Tropical Med Infect Dis. 2023;8(3):165.","journal-title":"Tropical Med Infect Dis"},{"issue":"3","key":"11093_CR16","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3390\/tropicalmed5030123","volume":"5","author":"KA Alene","year":"2020","unstructured":"Alene KA, Wangdi K, Clements AC. Impact of the COVID-19 pandemic on tuberculosis control: an overview. Tropical Med Infect Dis. 2020;5(3):123.","journal-title":"Tropical Med Infect Dis"},{"key":"11093_CR17","doi-asserted-by":"crossref","unstructured":"Lancet T. Tackling poverty in tuberculosis control. Lancet. 2005;366(9496):2063.","DOI":"10.1016\/S0140-6736(05)67862-2"},{"key":"11093_CR18","unstructured":"World Health Organization. WHO consolidated guidelines on tuberculosis. Module 2: screening-systematic screening for tuberculosis disease. Geneva: World Health Organization; 2021."},{"key":"11093_CR19","unstructured":"World Health Organization. (2023). Global Tuberculosis Report 2023. Geneva: WHO.https:\/\/www.who.int\/publications\/i\/item\/9789240083851."},{"issue":"2","key":"11093_CR20","doi-asserted-by":"publisher","first-page":"e0229040","DOI":"10.1371\/journal.pone.0229040","volume":"15","author":"A Shibabaw","year":"2020","unstructured":"Shibabaw A, Gelaw B, Gebreyes W, Robinson R, Wang SH, Tessema B. The burden of pre-extensively and extensively drug-resistant tuberculosis among MDR-TB patients in the Amhara region, Ethiopia. PLoS ONE. 2020;15(2):e0229040.","journal-title":"PLoS ONE"},{"key":"11093_CR21","unstructured":"Lessem E. Tuberculosis drug development hobbles forward. HIV\u2022 HCV\u2022 TB. 2014;197."},{"key":"11093_CR22","unstructured":"Stop TB Partnership. HIV and Tuberculosis: Factsheet. Geneva: Stop TB Partnership; 2015."},{"issue":"1","key":"11093_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-021-05967-2","volume":"21","author":"E Kizito","year":"2021","unstructured":"Kizito E, Musaazi J, Mutesasira K, Twinomugisha F, Namwanje H, Kiyemba T, Lopez DBF, Nicholas NS, Nkolo A, Birabwa E. Risk factors for mortality among patients diagnosed with multi-drug resistant tuberculosis in Uganda-a case-control study. BMC Infect Dis. 2021;21(1):1\u20137.","journal-title":"BMC Infect Dis"},{"issue":"12","key":"11093_CR24","doi-asserted-by":"publisher","first-page":"427","DOI":"10.15585\/mmwr.mm7012a4","volume":"70","author":"R Fukunaga","year":"2021","unstructured":"Fukunaga R, Glaziou P, Harris JB, Date A, Floyd K, Kasaeva T. Epidemiology of Tuberculosis and Progress Toward Meeting Global Targets\u2014Worldwide, 2019. Morb Mortal Wkly Rep. 2021;70(12):427.","journal-title":"Morb Mortal Wkly Rep"},{"key":"11093_CR25","unstructured":"World Bank. Learning from Burundi\u2019s Political Pivot on COVID-19 Vaccines. Available online: https:\/\/blogs.worldbank.org\/nasikiliza\/learning-burundis-political-pivot-covid-19-vaccines"},{"key":"11093_CR26","unstructured":"Xinhua. Burundi extends quarantine to travelers from U.S., Britain, Australia and China. 2020. Available from:\nhttp:\/\/www.china.org.cn\/world\/Off_the_Wire\/2020-03\/17\/content_75824457.htm\n."},{"key":"11093_CR27","unstructured":"Tasamba J. Travelers to Burundi to be quarantined for coronavirus . Anadolu Agency; 2020. Available from: https:\/\/www.aa.com.tr\/en\/africa\/travelers-to-burundi-to-be-quarantined-for-coronavirus\/1764008\n.\u00a0Cited 2025 Apr 14."},{"key":"11093_CR28","unstructured":"Reuters. Burundi launches COVID-19 vaccination drive . Reuters; 2021. Available from: https:\/\/www.reuters.com\/world\/africa\/burundi-launches-covid-19-vaccination-drive-2021-10-18\/. Cited 2025 Apr 14."},{"key":"11093_CR29","doi-asserted-by":"crossref","unstructured":"Nalunjogi J, Mucching-Toscano S, Sibomana JP, Centis R, D'Ambrosio L, Alffenaar J-W, Denholm J, Blanc F-X, Borisov S, Danila E: Impact of COVID-19 on diagnosis of tuberculosis, multidrug-resistant tuberculosis, and on mortality in 11 countries in Europe, Northern America, and Australia. A Global Tuberculosis Network study. Int J Infect Dis. 2023;130:S25-S29.","DOI":"10.1016\/j.ijid.2023.02.025"},{"issue":"10","key":"11093_CR30","first-page":"S18","volume":"94","author":"PW Wekunda","year":"2017","unstructured":"Wekunda PW, Kosgei RJ, Gathara D, Maore N, Masini E, Omesa EN, Kimenye K. Evaluation of treatment outcomes and associated factors among patients managed for tuberculosis in Vihiga County, 2012\u20132015. East Afr Med J. 2017;94(10):S18\u201327.","journal-title":"East Afr Med J"},{"issue":"7","key":"11093_CR31","doi-asserted-by":"publisher","first-page":"e0219191","DOI":"10.1371\/journal.pone.0219191","volume":"14","author":"OA Abdullahi","year":"2019","unstructured":"Abdullahi OA, Ngari MM, Sanga D, Katana G, Willetts A. Mortality during treatment for tuberculosis; a review of surveillance data in a rural county in Kenya. PLoS ONE. 2019;14(7):e0219191.","journal-title":"PLoS ONE"},{"issue":"12","key":"11093_CR32","doi-asserted-by":"publisher","first-page":"e0243977","DOI":"10.1371\/journal.pone.0243977","volume":"15","author":"RJ Kosgei","year":"2020","unstructured":"Kosgei RJ, Callens S, Gichangi P, Temmerman M, Kihara A-B, David G, Omesa EN, Masini E, Carter EJ. Gender difference in mortality among pulmonary tuberculosis HIV co-infected adults aged 15\u201349 years in Kenya. PLoS ONE. 2020;15(12):e0243977.","journal-title":"PLoS ONE"},{"issue":"4","key":"11093_CR33","first-page":"1080","volume":"39","author":"AM Akhtar","year":"2023","unstructured":"Akhtar AM, Kanwal S, Majeed S, Majeed W. Weight variation increases the risk of death during the intensive phase of treatment among MDR-TB patients: A retrospective study. Pakistan J Med Sci. 2023;39(4):1080.","journal-title":"Pakistan J Med Sci"},{"issue":"4","key":"11093_CR34","doi-asserted-by":"publisher","first-page":"514","DOI":"10.5588\/ijtld.18.0306","volume":"23","author":"J Musaazi","year":"2019","unstructured":"Musaazi J, Sekaggya-Wiltshire C, Kiragga A, Kalule I, Reynolds S, Manabe Y, Castelnuovo B. Sustained positive impact on tuberculosis treatment outcomes of TB-HIV integrated care in Uganda. Int J Tuberc Lung Dis. 2019;23(4):514\u201321.","journal-title":"Int J Tuberc Lung Dis"},{"key":"11093_CR35","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1016\/j.ijid.2021.02.107","volume":"113","author":"J Chakaya","year":"2021","unstructured":"Chakaya J, Khan M, Ntoumi F, Aklillu E, Fatima R, Mwaba P, Kapata N, Mfinanga S, Hasnain SE, Katoto PD. Global Tuberculosis Report 2020\u2013Reflections on the Global TB burden, treatment and prevention efforts. Int J Infect Dis. 2021;113:S7\u201312.","journal-title":"Int J Infect Dis"},{"issue":"6","key":"11093_CR36","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.3390\/jcm9061873","volume":"9","author":"F Ciza","year":"2020","unstructured":"Ciza F, Gils T, Sawadogo M, Decroo T, Roggi A, Piubello A, Ortu\u00f1o-Guti\u00e9rrez N. Course of adverse events during short treatment regimen in patients with rifampicin-resistant tuberculosis in Burundi. J Clin Med. 2020;9(6):1873.","journal-title":"J Clin Med"},{"key":"11093_CR37","doi-asserted-by":"publisher","unstructured":"Jee Y. WHO International Health Regulations Emergency Committee for the COVID-19 outbreak. Epidemiol Health. 2020;42:e2020013. https:\/\/doi.org\/10.4178\/epih.e2020013.","DOI":"10.4178\/epih.e2020013"},{"issue":"2","key":"11093_CR38","first-page":"e20","volume":"3","author":"NK Fahim","year":"2019","unstructured":"Fahim NK, Negida A, Fahim AK. Sample Size Calculation Guide - Part 3: How to Calculate the Sample Size for an Independent Case-control Study. Adv J Emerg Med. 2019;3(2):e20.","journal-title":"Adv J Emerg Med"},{"issue":"1","key":"11093_CR39","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13643-023-02175-8","volume":"12","author":"TJ Nicholson","year":"2023","unstructured":"Nicholson TJ, Hoddinott G, Seddon JA, Claassens MM, van der Zalm MM, Lopez E, Bock P, Caldwell J, Da Costa D, de Vaal C. A systematic review of risk factors for mortality among tuberculosis patients in South Africa. Syst Rev. 2023;12(1):23.","journal-title":"Syst Rev"},{"issue":"2","key":"11093_CR40","doi-asserted-by":"publisher","first-page":"49","DOI":"10.18231\/j.ijcaap.2020.012","volume":"5","author":"AA Zanke","year":"2020","unstructured":"Zanke AA, Thenge RR, Adhao VS. COVID-19: A pandemic declare by world health organization. IP Int J Compr and Adv Pharmacol. 2020;5(2):49\u201357.","journal-title":"IP Int J Compr and Adv Pharmacol"},{"issue":"8","key":"11093_CR41","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1080\/03610926.2018.1440598","volume":"48","author":"T Kamble","year":"2019","unstructured":"Kamble T, Kashid D, Sakate D. Consistent and robust variable selection in regression based on Wald test. Commun Stat Theory Methods. 2019;48(8):1981\u20132000.","journal-title":"Commun Stat Theory Methods"},{"key":"11093_CR42","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1751-0473-3-17","volume":"3","author":"Z Bursac","year":"2008","unstructured":"Bursac Z, Gauss CH, Williams DK, Hosmer DW. Purposeful selection of variables in logistic regression. Source Code Biol Med. 2008;3:17.","journal-title":"Source Code Biol Med"},{"key":"11093_CR43","doi-asserted-by":"crossref","unstructured":"Mohammad Ziaul Islam C, Tanvir CT. Variable selection strategies and its importance in clinical prediction modelling. Family Med Commun Health. 2020;8(1):e000262.","DOI":"10.1136\/fmch-2019-000262"},{"key":"11093_CR44","doi-asserted-by":"crossref","unstructured":"Hosmer DW Jr, Lemeshow S, Sturdivant RX. Applied Logistic Regression. 3rd ed. Hoboken, NJ: John Wiley & Sons; 2013.","DOI":"10.1002\/9781118548387"},{"issue":"3","key":"11093_CR45","doi-asserted-by":"publisher","first-page":"404","DOI":"10.4236\/ojs.2023.133020","volume":"13","author":"T Kyriazos","year":"2023","unstructured":"Kyriazos T, Poga M. Dealing with Multicollinearity in Factor Analysis: The Problem, Detections, and Solutions. Open J Stat. 2023;13(3):404\u201324.","journal-title":"Open J Stat"},{"issue":"1","key":"11093_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13040-023-00322-4","volume":"16","author":"D Chicco","year":"2023","unstructured":"Chicco D, Jurman G. The Matthews correlation coefficient (MCC) should replace the ROC AUC as the standard metric for assessing binary classification. BioData Mining. 2023;16(1):1\u201323.","journal-title":"BioData Mining"},{"issue":"12","key":"11093_CR47","doi-asserted-by":"publisher","first-page":"e853","DOI":"10.1016\/S2589-7500(22)00188-1","volume":"4","author":"AA de Hond","year":"2022","unstructured":"de Hond AA, Steyerberg EW, van Calster B. Interpreting area under the receiver operating characteristic curve. Lancet Digital Health. 2022;4(12):e853\u20135.","journal-title":"Lancet Digital Health"},{"issue":"1","key":"11093_CR48","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jeconom.2022.04.007","volume":"235","author":"X Zhang","year":"2023","unstructured":"Zhang X, Liu C-A. Model averaging prediction by K-fold cross-validation. J Econom. 2023;235(1):280\u2013301.","journal-title":"J Econom"},{"key":"11093_CR49","doi-asserted-by":"crossref","unstructured":"He Q, Zhang M, Zhang J, Yang S, Wang C: K-Fold Cross-Valuation for Machine Learning Using Shapley Value. In: International Conference on Artificial Neural Networks: 2023: Springer; 2023: 50\u201361.","DOI":"10.1007\/978-3-031-44213-1_5"},{"issue":"9","key":"11093_CR50","doi-asserted-by":"publisher","first-page":"e1323","DOI":"10.1016\/S2214-109X(23)00360-1","volume":"11","author":"HH Kyu","year":"2023","unstructured":"Kyu HH, Ledesma JR. What is the impact of the COVID-19 pandemic on tuberculosis? Lancet Glob Health. 2023;11(9):e1323\u20134.","journal-title":"Lancet Glob Health"},{"issue":"9","key":"11093_CR51","doi-asserted-by":"publisher","first-page":"e1412","DOI":"10.1016\/S2214-109X(23)00312-1","volume":"11","author":"H Surendra","year":"2023","unstructured":"Surendra H, Elyazar IR, Puspaningrum E, Darmawan D, Pakasi TT, Lukitosari E, Sulistyo S, Deviernur SM, Fuady A, Thwaites G. Impact of the COVID-19 pandemic on tuberculosis control in Indonesia: a nationwide longitudinal analysis of programme data. Lancet Glob Health. 2023;11(9):e1412\u201321.","journal-title":"Lancet Glob Health"},{"issue":"1","key":"11093_CR52","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12879-022-07078-y","volume":"22","author":"M Arentz","year":"2022","unstructured":"Arentz M, Ma J, Zheng P, Vos T, Murray CJ, Kyu HH. The impact of the COVID-19 pandemic and associated suppression measures on the burden of tuberculosis in India. BMC Infect Dis. 2022;22(1):92.","journal-title":"BMC Infect Dis"},{"issue":"8","key":"11093_CR53","doi-asserted-by":"publisher","first-page":"710","DOI":"10.5588\/ijtld.22.0006","volume":"26","author":"A Trajman","year":"2022","unstructured":"Trajman A, Felker I, Alves LC, Coutinho I, Osman M, Meehan S, Singh U, Schwartz Y. The COVID-19 and TB syndemic: The way forward. Int J Tuberc Lung Dis. 2022;26(8):710\u20139.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"06","key":"11093_CR54","doi-asserted-by":"publisher","first-page":"121","DOI":"10.53350\/pjmhs2023176121","volume":"17","author":"MU Abdullah","year":"2023","unstructured":"Abdullah MU, Imran A, Saulat A, Asmat F, Nadeem S, Ramzan M, Rafique MH, Rafique R. Socioeconomic Determinants of Pulmonary Tuberculosis during Covid-19 Pandemic: Case Control Study. Pakistan J MedHealth Sci. 2023;17(06):121\u2013121.","journal-title":"Pakistan J MedHealth Sci"},{"key":"11093_CR55","doi-asserted-by":"publisher","unstructured":"Nalunjogi J, Mucching-Toscano S, Sibomana JP, Centis R, D'Ambrosio L, Alffenaar J-W, Denholm J, Blanc F-X, Borisov S, Danila E. Impact of COVID-19 on diagnosis of TB, MDR-TB and on mortality in 11 countries in Europe, northern America and Australia: a Global Tuberculosis Network study. Int J Infect Dis. 2023;1:S25-S29. https:\/\/doi.org\/10.1016\/j.ijid.2023.02.025.","DOI":"10.1016\/j.ijid.2023.02.025"},{"issue":"2","key":"11093_CR56","doi-asserted-by":"publisher","first-page":"e59","DOI":"10.1016\/S1473-3099(22)00500-X","volume":"23","author":"T Ryckman","year":"2023","unstructured":"Ryckman T, Robsky K, Cilloni L, Zawedde-Muyanja S, Ananthakrishnan R, Kendall EA, Shrestha S, Turyahabwe S, Katamba A, Dowdy DW. Ending tuberculosis in a post-COVID-19 world: a person-centred, equity-oriented approach. Lancet Infect Dis. 2023;23(2):e59\u201366.","journal-title":"Lancet Infect Dis"},{"key":"11093_CR57","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.3389\/fmed.2021.740593","volume":"8","author":"M Koupaei","year":"2021","unstructured":"Koupaei M, Naimi A, Moafi N, Mohammadi P, Tabatabaei FS, Ghazizadeh S, Heidary M, Khoshnood S. Clinical characteristics, diagnosis, treatment, and mortality rate of TB\/COVID-19 coinfectetd patients: a systematic review. Front Med. 2021;8:2188.","journal-title":"Front Med"},{"issue":"4","key":"11093_CR58","doi-asserted-by":"publisher","first-page":"e0001758","DOI":"10.1371\/journal.pgph.0001758","volume":"3","author":"AV Easton","year":"2023","unstructured":"Easton AV, Salerno MM, Trieu L, Humphrey E, Kaba F, Macaraig M, Dworkin F, Nilsen DM, Burzynski J. Cohort study of the mortality among patients in New York City with tuberculosis and COVID-19, March 2020 to June 2022. PLOS Global Public Health. 2023;3(4):e0001758.","journal-title":"PLOS Global Public Health"},{"issue":"2","key":"11093_CR59","doi-asserted-by":"publisher","first-page":"e220","DOI":"10.52225\/narra.v3i2.220","volume":"3","author":"I Ichsan","year":"2023","unstructured":"Ichsan I, Redwood-Campbell L, Mahmud NN, Dimiati H, Yani M, Mudatsir M, Syukri M. Risk factors of MDR-TB and impacts of COVID-19 pandemic on escalating of MDR-TB incidence in lower-middle-income countries: A scoping review. Narra J. 2023;3(2):e220\u2013e220.","journal-title":"Narra J"},{"issue":"4","key":"11093_CR60","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.pulmoe.2020.05.002","volume":"26","author":"I Motta","year":"2020","unstructured":"Motta I, Centis R, D\u2019Ambrosio L, Garc\u00eda-Garc\u00eda J-M, Goletti D, Gualano G, Lipani F, Palmieri F, S\u00e1nchez-Montalv\u00e1 A, Pontali E. Tuberculosis, COVID-19 and migrants: preliminary analysis of deaths occurring in 69 patients from two cohorts. Pulmonology. 2020;26(4):233\u201340.","journal-title":"Pulmonology"},{"issue":"24","key":"11093_CR61","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1056\/NEJMc2010419","volume":"382","author":"P Goyal","year":"2020","unstructured":"Goyal P, Choi JJ, Pinheiro LC, Schenck EJ, Chen R, Jabri A, Satlin MJ, Campion TR Jr, Nahid M, Ringel JB. Clinical characteristics of Covid-19 in New York city. N Engl J Med. 2020;382(24):2372\u20134.","journal-title":"N Engl J Med"},{"issue":"5","key":"11093_CR62","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.4269\/ajtmh.20-0851","volume":"103","author":"SC Vilbrun","year":"2020","unstructured":"Vilbrun SC, Mathurin L, Pape JW, Fitzgerald D, Walsh KF. Case Report: Multidrug-Resistant Tuberculosis and COVID-19 Coinfection in Port-au-Prince. Haiti Am J Trop Med Hyg. 2020;103(5):1986\u20138.","journal-title":"Haiti Am J Trop Med Hyg"},{"issue":"4","key":"11093_CR63","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1177\/0958305X221079425","volume":"34","author":"Y Liu","year":"2023","unstructured":"Liu Y, Cao D, Cao X, Jain V, Chawla C, Shabbir MS, Ramos-Meza CS. The effects of MDR-TB treatment regimens through socioeconomic and spatial characteristics on environmental-health outcomes: evidence from Chinese hospitals. Energy Environ. 2023;34(4):1081\u201393.","journal-title":"Energy Environ"},{"issue":"1","key":"11093_CR64","doi-asserted-by":"publisher","first-page":"e001999","DOI":"10.1136\/bmjresp-2023-001999","volume":"11","author":"K Zereabruk","year":"2024","unstructured":"Zereabruk K, Kahsay T, Teklemichael H, Aberhe W, Hailay A, Mebrahtom G, Bezabh G. Determinants of multidrug-resistant tuberculosis among adults undergoing treatment for tuberculosis in Tigray Region, Ethiopia: a case\u2013control study. BMJ Open Respir Res. 2024;11(1):e001999.","journal-title":"BMJ Open Respir Res"},{"key":"11093_CR65","doi-asserted-by":"publisher","unstructured":"Olabiyi OE, Okiki PA, Adarabioyo MI, Adebiyi OE, Adegoke OE, Esan OE, Idris OO, Agunbiade TB. Distribution of multi-drug resistant tuberculosis in Ekiti and Ondo states, Nigeria. New Microbes New Infect. 2023; 53:101\u201392. https:\/\/doi.org\/10.1016\/j.nmni.2023.101192.","DOI":"10.1016\/j.nmni.2023.101192"},{"issue":"3","key":"11093_CR66","doi-asserted-by":"publisher","first-page":"e0280396","DOI":"10.1371\/journal.pone.0280396","volume":"18","author":"AW Mbuya","year":"2023","unstructured":"Mbuya AW, Mboya IB, Semvua HH, Mamuya SH, Msuya SE. Prevalence and factors associated with tuberculosis among the mining communities in Mererani, Tanzania. PLoS ONE. 2023;18(3):e0280396.","journal-title":"PLoS ONE"},{"key":"11093_CR67","doi-asserted-by":"publisher","unstructured":"de Dieu Longo J, Woromogo SH, Tekpa G, Diemer HS-C, Gando H, Djidere FA, Gr\u00e9senguet G. Risk factors for multidrug-resistant tuberculosis in the Central African Republic: a case control study. J Infect Public Health. 2023;9:1341\u20135. https:\/\/doi.org\/10.1016\/j.jiph.2023.06.007.","DOI":"10.1016\/j.jiph.2023.06.007"},{"key":"11093_CR68","doi-asserted-by":"publisher","unstructured":"Vyawahare C, Mukhida S, Khan S, Gandham NR, Kannuri S, Bhaumik S. Assessment of risk factors associated with drug-resistant tuberculosis in pulmonary tuberculosis patients. Indian J Tuberc. 2023;71:S44\u2013S51. https:\/\/doi.org\/10.1016\/j.ijtb.2023.07.007.","DOI":"10.1016\/j.ijtb.2023.07.007"},{"issue":"6","key":"11093_CR69","doi-asserted-by":"publisher","first-page":"e044349","DOI":"10.1136\/bmjopen-2020-044349","volume":"11","author":"N-n Tao","year":"2021","unstructured":"Tao N-n, Li Y-f, Song W-m, Liu J-y, Zhang Q-y, Xu T-t, Li S-j, An Q-q, Liu S-q, Li H-c. Risk factors for drug-resistant tuberculosis, the association between comorbidity status and drug-resistant patterns: A retrospective study of previously treated pulmonary tuberculosis in Shandong, China, during 2004\u20132019. BMJ Open. 2021;11(6):e044349.","journal-title":"BMJ Open"},{"issue":"1","key":"11093_CR70","doi-asserted-by":"publisher","first-page":"e061836","DOI":"10.1136\/bmjopen-2022-061836","volume":"13","author":"F Admassu","year":"2023","unstructured":"Admassu F, Abera E, Gizachew A, Sedoro T, Gari T. Risk factors of multidrug resistant tuberculosis among patients with tuberculosis at selected multidrug resistance treatment initiative centres in southern Ethiopia: a case-control study. BMJ Open. 2023;13(1):e061836.","journal-title":"BMJ Open"},{"key":"11093_CR71","doi-asserted-by":"publisher","unstructured":"Mohite RV. Knowledge on the risk factors of drug-resistant tuberculosis among newly diagnosed patients of tuberculosis with first-line antitubercular treatment regimen. BLDE Univ J Health Sci. 2023;8:238\u201343. https:\/\/doi.org\/10.4103\/bjhs.bjhs_217_22.","DOI":"10.4103\/bjhs.bjhs_217_22"},{"key":"11093_CR72","unstructured":"World Health Organization. Global tuberculosis report 2013. Geneva: World Health Organization; 2013."},{"issue":"2","key":"11093_CR73","doi-asserted-by":"publisher","first-page":"386","DOI":"10.4269\/ajtmh.18-0281","volume":"100","author":"W Muttamba","year":"2019","unstructured":"Muttamba W, Kirenga B, Ssengooba W, Sekibira R, Katamba A, Joloba ML. Prevalence of tuberculosis risk factors among bacteriologically negative and bacteriologically confirmed tuberculosis patients from five regional referral hospitals in Uganda. Am J Trop Med Hyg. 2019;100(2):386.","journal-title":"Am J Trop Med Hyg"},{"issue":"4","key":"11093_CR74","first-page":"284","volume":"7","author":"B Irawan","year":"2022","unstructured":"Irawan B, Sumardiyono S, Murti B. Meta-Analysis: Smoking and Proverty as Risk Factors of Tuberculosis Multidrug Resistance. J Health Promotion Behav. 2022;7(4):284\u201398.","journal-title":"J Health Promotion Behav"},{"key":"11093_CR75","doi-asserted-by":"publisher","unstructured":"Goel S, Bhatt G. The unequivocal relationship between tuberculosis and tobacco: integration of two maladies. In: Tuberculosis: Integrated Studies for a Complex Disease. Springer; 2023. p. 59\u201378. https:\/\/doi.org\/10.1007\/978-3-031-15955-8.","DOI":"10.1007\/978-3-031-15955-8"},{"key":"11093_CR76","doi-asserted-by":"publisher","unstructured":"Khattak M, Mushtaq U, Latif M, Ahmad I, Rasool MF, Shakeel S, Hayat K, Hussain R, Alhazmi GA, Alshomrani AO. The impact of diabetes mellitus on the emergence of multi-drug resistant tuberculosis and treatment failure in TBdiabetes comorbid patients: a systematic review and meta-analysis. Front Public Health. 2023;11:1244450. https:\/\/doi.org\/10.3389\/fpubh.2023.1244450.","DOI":"10.3389\/fpubh.2023.1244450"},{"key":"11093_CR77","doi-asserted-by":"publisher","unstructured":"Chen Y, Liu J, Zhang Q, Chen H, Chai L, Wang Y, Zhang J, Qiu Y, Shen N, Shi X. Global burden of MDR-TB and XDRTB attributable to high fasting plasma glucose from 1990 to 2019: a retrospective analysis based on the global burden of disease study 2019. Eur J Clin Microbiol Infect Dis. 2024;43(4):747\u201365. https:\/\/doi.org\/10.1007\/s10096-024-04779-x.","DOI":"10.1007\/s10096-024-04779-x"},{"key":"11093_CR78","doi-asserted-by":"publisher","unstructured":"Liberty P, Liberty M. Type 2 diabetes mellitus and pulmonary tuberculosis: literature review of a bidirectional relationship. Scripta Score Sci Med J. 2023;5(1). https:\/\/doi.org\/10.32734\/scripta.v5i1.11517.","DOI":"10.32734\/scripta.v5i1.11517"},{"issue":"4","key":"11093_CR79","doi-asserted-by":"publisher","first-page":"284","DOI":"10.5588\/ijtld.22.0685","volume":"27","author":"D Goletti","year":"2023","unstructured":"Goletti D, Pisapia R, Fusco F, Aiello A, Van Crevel R. Epidemiology, pathogenesis, clinical presentation and management of TB in patients with HIV and diabetes. Int J Tuberc Lung Dis. 2023;27(4):284\u201390.","journal-title":"Int J Tuberc Lung Dis"},{"key":"11093_CR80","doi-asserted-by":"publisher","unstructured":"Semianiv I, Todoriko L, Semianiv M, Garas M, Todoriko L. Predicting the efficiency of the treatment of comorbidity diabetes mellitus and multidrug-resistant tuberculosis depending on the polymorphism variation of glutathione-S-transferase genes. Eur Respir J. 2023;62(suppl 67):PA2958. https:\/\/doi.org\/10.1183\/13993003.congress-2023.PA2958.","DOI":"10.1183\/13993003.congress-2023.PA2958"},{"key":"11093_CR81","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1016\/j.ijid.2023.04.024","volume":"130","author":"J Jagtap","year":"2023","unstructured":"Jagtap J, Atre S, Dumbare Y, Faqih M, Sawant T, Ambike S, Bhawalkar J, Farhat M. Health system related barriers to multidrug-resistant tuberculosis (MDR-TB) care in an indian setting: from patients\u2019perspective. Int J Infect Dis. 2023;130:S8.","journal-title":"Int J Infect Dis"},{"key":"11093_CR82","unstructured":"World Health Organization (WHO). (2025, April 16). WHO consolidated guidelines on tuberculosis: Module 3: Diagnosis. WHO.https:\/\/www.who.int\/publications\/i\/item\/9789240107984."},{"key":"11093_CR83","doi-asserted-by":"crossref","unstructured":"da Costa C, Benn CS, Nyirenda T, Mpabalwani E, Grewal HM, Ahmed R, Kapata N, Nyasulu PS, Maeurer M, Hui DS: Perspectives on Development and Advancement of New Tuberculosis Vaccines. Int J Infect Dis. 2024:106987.","DOI":"10.1016\/j.ijid.2024.106987"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11093-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11093-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11093-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T18:03:00Z","timestamp":1747504980000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11093-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,17]]},"references-count":83,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11093"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11093-0","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,17]]},"assertion":[{"value":"8 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by an institutional ethics committee of Kamenge Teaching Hospital (N\/Ref.2022\/DGCHUK836\/11.5). The study met the criteria for exemption from the regulations found at 45 CFR46.104(d) (4). No informed consent was needed. The Harvard T.H. Chan School of Public Health IRB office (RB23-1209) has, additionally, waived the requirement for informed consent. All data were fully anonymized before we accessed them. The study was conducted by the guidelines of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"716"}}